IGF2BP3 and urinary bladder carcinoma: To determine the pathways associated with IGF2BP3 expression in bladder cancer, we utilized Gene Set Enrichment Analysis (GSEA) to identify gene sets that exhibited enrichment or depletion in tumors with high IGF2BP3 expression.